Clinically relevant information from sentinel lymph node biopsies of melanoma patients

Journal of Surgical Oncology

Volumn 104, Issue 4, 2011, Pages 369-378

  Wen, Duan Ren ^a   Cochran, Alistair J ^a   Huang, Rong Rong ^a   Itakura, Eijun ^a   Binder, Scott ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

immunohistochemistry; melanoma; micrometastases; microscopy; molecular biology; pathology; prognosis; sentinel lymph nodes

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; MELAN A; MONOCLONAL ANTIBODY HMB 45; PROTEIN P16;

CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MASS SPECTROMETRY; MELANOMA; MELANOMA CELL; MELANOMA METASTASIS; METASTASIS; MICROSCOPY; NEEDLE BIOPSY; PRIORITY JOURNAL; RADIOACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STAINING; SURGICAL TECHNIQUE; TREATMENT PLANNING;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 80051962551     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21818     Document Type: Review

References (57)

1. Morton DL, Wen D-R, Foshag LJ, et al.: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanomas of the head and neck. J Clin Oncol 1993; 11: 1751-1756. (Pubitemid 23277328)
2. Cochran AJ, Balda B-R, Starz H, et al.: The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89: 236-241. (Pubitemid 30489868)
3. Cochran AJ, Roberts A, Wen D-R, et al.: Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumors. Pathology 2004; 36: 478-484. (Pubitemid 39273993)
4. Cochran AJ, Starz H, Ohsie SJ, et al.: Pathologic reporting and special diagnostic techniques for melanoma. Surg Oncol Clin N Am 2006; 5: 231-251.
5. McKee PH,. Pathology of the skin, chapter 28, 4th edition. Elsevier (in press).
6. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
7. Cochran AJ, Wen D-R, Morton DL:, Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 1988; 12: 612-618.
8. Fee HJ, Robinson DS, Sample WF, et al.: The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: A preliminary study. Surgery 1978; 84: 626-632. (Pubitemid 9049936)
9. Pijpers R, Borgstein PJ, Meijer S, et al.: Sentinel node biopsy in melanoma patients: Dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788-792.
10. Wong JH, Cagle LA, Morton DL:, Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991; 214: 637-641.
11. Morton DL, Cochran AJ, Thompson JF, et al.: Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-311.
12. Morton DL, Thompson JF, Cochran AJ, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317. (Pubitemid 44465459)
13. Uren RF, Howman-Giles R, Thompson JF, et al.: High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol 1999; 43: 148-152. (Pubitemid 29260073)
14. Voit C, Schoengen A, Schwürzer-Voit M, et al.: The role of ultrasound in detection and management of regional disease in melanoma patients. Semin Oncol 2002; 29: 353-360. (Pubitemid 34857883)
15. Haigh PI, Lucci A, Turner RR, et al.: Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer 2001; 92: 535-541. (Pubitemid 32735188)
16. Morton DL, Hoon DS, Cochran AJ, et al.: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238: 538-549.
17. Dawson M, Doble P, Beavis A, et al.: Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst 2003; 128: 217-219. (Pubitemid 36390580)
18. Scolyer RA, Thompson JF, Li LX, et al.: Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004; 17: 1191-1197. (Pubitemid 39312945)
19. Stojadinovic A, Allen PJ, Clary BM, et al.: Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 2002; 235: 92-98. (Pubitemid 34062404)
20. Scolyer RA, Thompson JF, McCarthy SW, et al.: Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 2005; 201: 821-823.
21. Cochran AJ, Morton DL:, Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes. Am J Surg Pathol 2006; 30: 419-420. (Pubitemid 43740180)
22. Starz H, Balda BR, Krämer KU, et al.: A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91: 2110-2121. (Pubitemid 32476376)
23. Cook MG, Green MA, Anderson B, et al.: The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003; 200: 314-319. (Pubitemid 36827305)
24. Spanknebel K, Coit DG, Bieligk SC, et al.: Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: Recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005; 29: 305-317. (Pubitemid 40321965)
25. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al.: Sentinel lymph nodes in malignant melanoma: Extended histopathologic evaluation improves diagnostic precision. Cancer 2004; 100: 1683-1691. (Pubitemid 38456346)
26. Riber-Hansen R, Sjoegren P, Hamilton-Dutoit SJ, et al.: Extensive pathological analysis of selected melanoma sentinel lymph nodes: High metastasis detection rates at reduced workload. Ann Surg Oncol 2008; 15: 1492-1501.
27. Scolyer RA, Thompson JF, McCarthy SW:, Sentinel lymph nodes in malignant melanoma: Extended histopathologic evaluation improves diagnostic precision. Cancer 2004; 101: 2141-2142.
28. Cochran AJ, Huang RR, Lee J, et al.: Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 2006; 6: 659-670. (Pubitemid 44298215)
29. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al.: Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008; 35: 433-444. (Pubitemid 351519417)
30. Carson KF, Wen DR, Li PX, et al.: Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996; 20: 834-840. (Pubitemid 26230746)
31. Witte ME, Gerrits EG, Klaase JM, et al.: Distinguishing nodal naevus from melanoma metastases in the sentinel node in patients with melanoma. Ned Tijdschr Geneeskd 2006; 150: 1072-1076. (Pubitemid 43780027)
32. Brennick JB, Yan S:, False-positive cells in sentinel lymph nodes. Semin Diagn Pathol 2008; 25: 116-119. (Pubitemid 351885454)
33. Mihic-Probst D, Saremaslani P, Komminoth P, et al.: Immunostaining for the tumour suppressor gene p16 product is a useful marker to differentiate melanoma metastasis from lymph-node nevus. Virchows Arch 2003; 443: 745-751. (Pubitemid 38030628)
34. Lohmann CM, Iversen K, Jungbluth AA, et al.: Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol 2002; 26: 1351-1357.
35. Biddle DA, Evans HL, Kemp BL, et al.: Intraparenchymal nevus cell aggregates in lymph nodes: A possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 2003; 27: 673-681. (Pubitemid 36514478)
36. Kelley SW, Cockerell CJ:, Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: A proposal. J Am Acad Dermatol 2000; 42: 527-530. (Pubitemid 30470370)
37. Zuckerman R, Maier JP, Guiney WB, Jr., et al.: Pediatric melanoma: Confirming the diagnosis with sentinel node biopsy. Ann Plast Surg 2001; 46: 394-399. (Pubitemid 32319677)
38. Lohmann CM, Coit DG, Brady MS, et al.: Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002; 26: 47-55. (Pubitemid 34019991)
39. Su LD, Fullen DR, Sondak VK, et al.: Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: A report on 18 patients. Cancer 2003; 97: 499-507. (Pubitemid 36133818)
40. Murali R, Sharma RN, Thompson JF, et al.: Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol 2008; 15: 302-309.
41. Cochran AJ, Binder S, Morton DL:, The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions. J Cutan Pathol 2010; 37: 54-59.
42. Starz H, Haas CJ, Schulz GM, et al.: Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes. Mod Pathol 2003; 16: 920-929. (Pubitemid 37152022)
43. Mocellin S, Hoon DS, Pilati P, et al.: Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis. J Clin Oncol 2007; 25: 1588-1595. (Pubitemid 46733087)
44. Cochran AJ:, A glimpse of future management of melanoma. Arch Dermatol 2009; 145: 1176-1177.
45. Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634. (Pubitemid 32786275)
46. Cochran AJ, Lana AM, Wen DR:, Histomorphometry in the assessment of prognosis in stage II malignant melanoma. Am J Surg Pathol 1989; 13: 600-604. (Pubitemid 19185794)
47. Wagner JD, Davidson D, Coleman JJ III, et al.: Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999; 6: 398-404. (Pubitemid 29260805)
48. Cochran AJ, Wen DR, Huang RR, et al.: Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004; 17: 747-755. (Pubitemid 38843356)
49. Dewar DJ, Newell B, Green MA, et al.: The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22: 3345-3349. (Pubitemid 41103692)
50. van Akkooi AC, de Wilt JH, Verhoef C, et al.: Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: Are these nodes to be considered negative ? Ann Oncol 2006, 17: 1578-1585. (Pubitemid 44542045)
51. Govindarajan A, Ghazarian DM, McCready DR, et al.: Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007; 14: 906-912. (Pubitemid 46175342)
52. Scheri RP, Essner R, Turner RR, et al.: Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007; 14: 2861-2866. (Pubitemid 47460638)
53. Scolyer RA, Li LX, McCarthy SW, et al.: Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004; 122: 532-539. (Pubitemid 39281249)
54. Van der Ploeg I, Nieweg O, Valdés Olmos R, et al.: Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node ? Ann Surg Oncol 2008; 15: 17.
55. Starz H:, Pathology of the sentinel lymph node in melanoma. Semin Oncol 2004; 31: 357-362. (Pubitemid 38869513)
56. Scolyer RA, Li LX, McCarthy SW, et al.: Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. Melanoma Res 2004; 14: 263-268. (Pubitemid 39159138)
57. Wen D-R, Huang R-R, Binder S, et al.: Evaluation of melanoma in non-sentinel nodes: How much is enough ? Mod Pathol 2004; 17: 100.